We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States
Price data last checked 107 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Product Specifications
- Format
- paperback
- ASIN
- B0BLQF7XM2
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 09 November 2022
Similar Products You Might Like
96% match
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
£520.00
14 Jan 2026
96% match
The 2023-2028 Outlook for Insomnia Therapeutics in the United States
£520.00
15 Jan 2026
96% match
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States
£520.00
29 Jan 2026
96% match
The 2023-2028 Outlook for Therapeutic Plasma Exchange for Neurological Disorders in the United States
£520.00
09 Jan 2026
96% match
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
£520.00
05 Feb 2026
96% match
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States
£520.00
28 Jan 2026
96% match
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States
£520.00
06 Feb 2026
96% match
The 2023-2028 Outlook for Neurostimulation Devices in the United States
£520.00
14 Jan 2026
96% match
The 2023-2028 Outlook for Topical Vitiligo Therapeutics in the United States
£520.00
30 Jan 2026
96% match
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in the United States
£520.00
30 Jan 2026
96% match
The 2023-2028 Outlook for External Neurostimulation in the United States
£520.00
14 Jan 2026
96% match
The 2023-2028 Outlook for HIV and AIDS Therapeutics in the United States
£520.00
14 Jan 2026
96% match
The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States
£520.00
12 Jan 2026
96% match
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
£520.00
05 Feb 2026
96% match
The 2023-2028 Outlook for Erythropoietin Drugs in the United States
£520.00
06 Feb 2026
96% match
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
£520.00
03 Feb 2026
96% match
The 2023-2028 Outlook for Anti-Malarial Drugs in the United States
£520.00
25 Jan 2026
96% match
The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in the United States
£520.00
30 Jan 2026
96% match
The 2023-2028 Outlook for Therapeutic Drug Monitoring in the United States
£520.00
22 Jan 2026
96% match
The 2023-2028 Outlook for MRSA Drugs in the United States
£520.00
31 Jan 2026
96% match
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
£520.00
05 Feb 2026
96% match
The 2023-2028 Outlook for Kinase Inhibitors in the United States
£520.00
10 Jan 2026
96% match
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
£520.00
14 Jan 2026
96% match
The 2023-2028 Outlook for Motion Sickness Treatments in the United States
£520.00
31 Jan 2026